SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-037581
Filing Date
2023-08-03
Accepted
2023-08-03 07:16:32
Documents
72
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kymr-20230630.htm   iXBRL 10-Q 3501999
2 EX-31.1 kymr-ex31_1.htm EX-31.1 21536
3 EX-31.2 kymr-ex31_2.htm EX-31.2 21327
4 EX-32.1 kymr-ex32_1.htm EX-32.1 12263
5 EX-32.2 kymr-ex32_2.htm EX-32.2 12053
  Complete submission text file 0000950170-23-037581.txt   11819749

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kymr-20230630_pre.xml EX-101.PRE 382648
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kymr-20230630_lab.xml EX-101.LAB 546376
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kymr-20230630_cal.xml EX-101.CAL 52906
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kymr-20230630.xsd EX-101.SCH 69240
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kymr-20230630_def.xml EX-101.DEF 242036
66 EXTRACTED XBRL INSTANCE DOCUMENT kymr-20230630_htm.xml XML 2390773
Mailing Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39460 | Film No.: 231138049
SIC: 2836 Biological Products, (No Diagnostic Substances)